A practical reference on GHRH: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
They rendezvous with local Interpol agent Gail Runciter and proceed to the safehouse, where an elderly Zola, in a wheelchair and requiring an oxygen mask, seemingly overpowers Kate Neville's telepathy with his evil visions of destruction. Runciter lures Fury away from the group and shocks him with a device before revealing herself to be Viper in disguise. She then kisses Fury with poisoned lipstick, leaving him unconscious, enabling Hydra to retake Zola. Fury learns he has 48 hours to live unless he can recover a sample of Viper's DNA from which to develop an antidote. Hydra threatens to attack Manhattan with the virus, barring payment of US $1 billion, and as proof of their threat, the real Gail Runciter is found, dying from the virus. After Fury and his team brief the President of the United States, Pierce determines from a chip from a laptop sold in the Aleutian Islands that the Hydra base might be there. Fury has his people split into two teams, one led by de Fontaine heading to Manhattan to find the refrigerated truck they believe will be needed to deploy the virus, and the other with Fury leading Pierce and Neville to the Aleutian Islands. Upon arriving in the Aleutian Islands and confirming that a Hydra transmission has come from there, Fury's plane is shot down by heat-seeking missiles. In Manhattan, de Fontaine's team figures out that the refrigerator truck is disguised as a garbage truck, while Fury and his team, having bailed out of the airplane in time, infiltrate the Hydra base.
== Release of GST-A1 as an indication of cellular necrosis == Increases in serum and urinary GST-A1 have been found in association with hepatocyte and renal proximal tubular necrosis respectively, and have potential for monitoring injury to these tissues.
It has since been elucidated that androgens like testosterone and dihydrotestosterone (DHT) function as trophic factors for the prostate gland, stimulating cell division and proliferation and producing tissue growth and glandular enlargement, which, in the context of prostate cancer, results in stimulation of tumors and a considerable acceleration of disease progression. As a result of these discoveries, androgen deprivation therapy (ADT), via a variety of modalities including surgical castration, high-dose estrogens, SAAs, GnRH analogues, NSAAs, and androgen biosynthesis inhibitors (e.g., abiraterone acetate), has become the mainstay of treatment for prostate cancer. Although ADT can shrink or stabilize prostate tumors and hence significantly slow the course of prostate cancer and prolong life, it is not generally curative. While effective in slowing the progression of the disease initially, most advanced prostate cancer patients eventually become resistant to ADT and prostate cancer growth starts to accelerate again, in part due to progressive mutations in the androgen receptor (AR) that result in the transformation of drugs like bicalutamide from AR antagonists to agonists. A few observations form the basis of the reasoning behind combined androgen blockade (CAB), in which castration and an NSAA are combined. It has been found that very low levels of androgens, as in castration, are able to significantly stimulate growth of prostate cancer cells and accelerate disease progression.
== See also == History of radar Acoustic mirror Battle of the Beams British military history of World War II Chain Home Low Civilian Technical Corps Ground-controlled interception ROTOR RAF Air Defence Radar Museum Castles in the Sky (film)
Members of the group held no voting privileges, so they could not affect the outcome of the parent group. The Order evolved into other fraternal groups during the 1920s. Teepee Order of America - Founded in 1915 by Red Fox Francis St. James, an alleged Blackfoot Indian. Open to Indians and non-Indians from the US, Canada, and Latin America, it excluded blacks and European immigrants. Originally similar to the Boy Scouts of America in appealing to youth and "focusing on Indian activities and ceremonies that were romantic in nature." It was a Pan-Indian group, but not as successful as the Society of American Indians, though there was some membership overlap. It advocated for Native American citizenship and questioned the efficacy of the Bureau of Indian Affairs.
Sources: en.wikipedia.org
In John Gould's Handbook to the Birds of Australia, first published in 1865, he lamented the loss of the emu from Tasmania, where it had become rare and has since become extinct; he noted that emus were no longer common in the vicinity of Sydney and proposed that the species be given protected status. In the 1930s, emu killings in Western Australia peaked at 57,000, and culls were also mounted in Queensland during this period due to rampant crop damage. In the 1960s, bounties were still being paid in Western Australia for killing emus, but since then, wild emus have been granted formal protection under the Environment Protection and Biodiversity Conservation Act 1999. Their occurrence range is between 4,240,000 and 6,730,000 km2 (1,640,000–2,600,000 sq mi), and a 1992 census suggested that their total population was between 630,000 and 725,000. Their population trend is thought to be stable and the International Union for Conservation of Nature assesses their conservation status as being of least concern. The isolated emu population of the New South Wales North Coast Bioregion and Port Stephens is listed as endangered by the New South Wales Government. Although the population of emus on mainland Australia is thought to be higher now than it was before European settlement, some local populations are at risk of extinction. The threats faced by emus include the clearing and fragmentation of areas of suitable habitat, deliberate slaughter, collisions with vehicles and predation of the eggs and young.
== Adverse effects == Ten to forty percent of people will experience nausea, vomiting, abdominal pain, itching skin, increased body temperature, trembling and weakness. One to five percent of peoples may experience back and chest pain, dizziness, anemia, chills and sweating, metallic taste, tachycardia and respiratory distress. Contraindications for the use of carbetocin include inappropriate timing during labor and delivery (such as before parturition or to induce labor) or allergic reactions to carbetocin or other oxytocin homologues. Additionally, carbetocin should not be used if a person has high blood pressure or cardiovascular problems. Overdosage or repeated use of carbetocin, particularly if used during pregnancy, could cause hyper-excitation of the oxytocin receptors resulting in excessive and prolonged stimulation of uterine contractions, increasing risk of uterine rupture, placental abruption, fetal respiratory distress and postpartum hemorrhage.
Organized crime groups also do a range of business and labor racketeering activities, such as skimming casinos, insider trading, setting up monopolies in industries such as garbage collecting, construction and cement pouring, bid rigging, getting "no-show" and "no-work" jobs, political corruption and bullying.
== Regenerative medicine applications == The MRL/MpJ mouse has attracted considerable attention in the field of regenerative medicine owing to its remarkable capacity for tissue repair in the absence of fibrosis. Insights derived from this model have been investigated for their potential translational relevance to human therapies. One major area of interest is scarless wound healing. The ability of MRL/MpJ mice to regenerate injured tissues without forming scar tissue provides a valuable model for elucidating mechanisms that may help reduce fibrosis in human cutaneous injuries and post-surgical healing. Cardiac regeneration represents another promising avenue. Experimental studies have demonstrated that MRL/MpJ mice are capable of partial myocardial regeneration following injury, suggesting potential strategies for promoting cardiac repair after myocardial infarction. Furthermore, this strain has been employed to investigate mechanisms underlying skeletal muscle repair. Its relative resistance to muscular degeneration has provided insights into potential therapeutic approaches for neuromuscular disorders, including muscular dystrophy. In addition, studies of the MRL/MpJ model have contributed to understanding the role of metabolic regulation in tissue repair. Notably, resistance to diet-induced hyperglycemia in this strain may offer insights into improving wound healing in diabetic conditions.
By March 2002, the Yorkshire-Tricon multi-branding test consisted of 83 KFC/A&Ws, six KFC/Long John Silver's, and three Taco Bell/Long John Silver's and was considered successful by the companies. In December 2000, A&W announced new openings in less conventional locations, such as casinos, airports, gas stations, convention centers and convenience stores, for 2001, as part of its growth plans. At the time, the chain had more than 1,000 locations in 47 states and over 200 international locations in 14 countries. The chain around the time emphasized its aesthetics on "contemporized nostalgia". It also saw a success in co-branded restaurants, following the success of a trial in Butte in 1998, which, owing to its success, in the spring of 2000 led to the announcement of the opening of 300 joint KFC-A&W restaurants by 2005. Tricon bought both A&W and LJS in March 2002, shortly before the merger with Yorkshire was finalized.
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.